Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma CellsKaisa Erjala, Klaus Elenius|Clinical Cancer Research|2006Cited by 265
Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1α SignalingIlkka Paatero, Klaus Elenius|Journal of Biological Chemistry|2012Cited by 44
An unbiased in vitro screen for activating epidermal growth factor receptor mutationsDeepankar Chakroborty, Klaus Elenius|Journal of Biological Chemistry|2019Cited by 28
The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migrationVeera K. Ojala, Klaus Elenius|Journal of Biological Chemistry|2020Cited by 17
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatinElli Narvi, Klaus Elenius|Scientific Reports|2018Cited by 11